Drug Trends
A word from Amélie Gagnon
The pharmaceutical field is rapidly evolving, and these changes influence both the health of the population and the costs of group insurance plans. New treatments are emerging, chronic illnesses are on the rise, and social issues such as the opioid crisis continue to have a major impact.
Current trends aside, there are many new developments to monitor over the next few years, including drugs for early-onset Alzheimer's, new treatments for obesity and diabetes, and solutions for widespread chronic diseases. Our team of pharmacists is committed to assessing these treatments and proposing responsible drug management solutions in order to preserve the long-term sustainability of our plans, while supporting the health of our insured members.
This bulletin aims to provide an overview of these trends to help our clients better understand the impact of these changes on their plans.
Amélie Gagnon
Vice-President, Transformation and Products Group Benefits and Retirement Savings